Chatterjee, Chirantan
Loading...
4
0
5
0
false
Loading...
2
0
5
0
false
Full Name
Chatterjee, Chirantan
Vernacular Name
Chirantan Chatterjee
Variants
Chirantan Chatterjee
Main Affiliation
Scopus Author ID
Loading...
3
0
5
0
false
Results 1-20 of 20 (Search time: 0.003 seconds).
Issue Date | Title | Sub-Title | Author(s) | Journal Name | Volume Number | Issue Number | Pages | |
---|---|---|---|---|---|---|---|---|
1 | 2011 | An economist among biologists (or maybe vice versa!) | - | Chatterjee, Chirantan | ||||
2 | 2015 | Balancing affordability and availability in a drug patent regime | - | Chatterjee, Chirantan ; Pingali, Viswanath | Economic and Political Weekly | Vol.50 | Iss.41 | 20-23p. |
3 | 2016 | Competition law in India: perspectives | - | Pingali, Viswanath ; Chaudhuri, Manas Kumar ; Malik, Payal ; Tamara, Ram ; Kakkar, Avaantika ; Chatterjee, Chirantan ; Mondal, Shamim ; Sokol, D Daniel | Vikalpa | Vol.41 | Iss.2 | 168-193p. |
4 | 2013 | Crocin or paracetamol: what should the doctor prescribe? | - | Chatterjee, Chirantan ; Kubo, Kensuke ; Pingali, Viswanath | Economic and Political Weekly | Vol.48 | Iss.41 | 20-22p. |
5 | 2013 | Ethical issues in health care sector in India | - | Chatterjee, Chirantan ; Srinivasan, Vasanthi | IIMB Management Review | Vol.25 | Iss.1 | 49-62p. |
6 | 25-Dec-2015 | From labs to markets, the emerging market for biological drugs in India | - | Chatterjee, Chirantan | India Abroad | |||
7 | 2018 | Gender and its rising role in modern Indian innovation and entrepreneurship | - | Chatterjee, Chirantan ; Ramu, Swapnika | IIMB Management Review | Vol.30 | Iss.1 | 62-72p. |
8 | 2018 | Government health insurance and spatial peer effects: new evidence from India | - | Chatterjee, Chirantan ; Joshi, Chirantan ; Sood, Neeraj ; Boregowda, P | Social Science and Medicine | Vol.196 | 131-141p. | |
9 | 2016 | Hit where it hurts: Cartel policing using targeted sales and supply embargoes | - | Bhaskarabhatla, Ajay ; Chatterjee, Chirantan ; Karreman, Bas | Journal of Law and Economics | Vol.59 | Iss.4 | 805-846p. |
10 | 23-Apr-2016 | India will have to decide whether it wants to get serious about R&D by taking IPR seriously | - | Chatterjee, Chirantan | The Economic Times | |||
11 | 13-Nov-2015 | Is India ready to reset its innovation mojo? | - | Chatterjee, Chirantan | LiveMint | |||
12 | 3-Sep-2015 | Is the new 'Mann der Tats' changing Indian society? | - | Chatterjee, Chirantan | Hindustan Times | |||
13 | 2011 | It’s time for De-Novo thinking in Indian pharmaceutical policy making | - | Chatterjee, Chirantan | ||||
14 | 17-Jan-2015 | It’s time to ratchet up India’s intellectual property stance | - | Chatterjee, Chirantan | Hindustan Times | |||
15 | 2017 | Mitigating regulatory impact : the case of partial price controls on metformin in India | - | Bhaskarabhatla, Ajay ; Chatterjee, Chirantan ; Anurag, Priyatam ; Pennings, Enrico | Health Policy And Planning | Vol.32 | Iss.2 | 194-204p. |
16 | 2016 | Regulation and welfare: Evidence from paragraph IV generic entry in the pharmaceutical industry | - | Branstetter, Lee ; Chatterjee, Chirantan ; Higgins, Matthew J | Rand Journal of Economics | Vol.47 | Iss.4 | 857-890p. |
17 | 16-Dec-2016 | State-championed or private low-end disruption! Who will win this horse race in steady state? | - | Chatterjee, Chirantan | The Economic Times | |||
18 | 2015 | The consumer welfare implications of governmental policies and firm strategy in markets for medicines | - | Chatterjee, Chirantan ; Kubo, Kensuke ; Pingali, Viswanath | Journal of Health Economics | Vol.44 | 255-273p. | |
19 | 2017 | The role of physicians in prescribing irrational fixed-dose combination medicines in India | - | Bhaskarabhatla, Ajay ; Chatterjee, Chirantan | Social Science and Medicine | Vol.174 | 179-187p. | |
20 | 20-Jul-2016 | What India must do to create Its own world-class academic journals | - | Chatterjee, Chirantan | The wire |